ResearcherSt. John's UniversityActive in the last 2 years

Shraddha P. Bhutkar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0137-4528; OpenAlex author ID A5064406563. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers16152713 ↗
In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. Co-author DOI 10.1016/j.yexcr.2021.112660 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ketan R. Patel · 2 shared papers, 2021–2024 · strength 0.43
- Paper Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. DOI 10.3390/cancers16152713 ↗
- Paper In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. DOI 10.1016/j.yexcr.2021.112660 ↗
Vikas V. Dukhande · 2 shared papers, 2021–2024 · strength 0.43
- Paper Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. DOI 10.3390/cancers16152713 ↗
- Paper In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. DOI 10.1016/j.yexcr.2021.112660 ↗
Anjali Yadav · 1 shared paper, 2024 · strength 0.26
- Paper Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. DOI 10.3390/cancers16152713 ↗
Aishwarya L. Saraswat · 1 shared paper, 2021 · strength 0.17
- Paper In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. DOI 10.1016/j.yexcr.2021.112660 ↗
Manali Patki · 1 shared paper, 2021 · strength 0.17
- Paper In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. DOI 10.1016/j.yexcr.2021.112660 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.